GE Aerospace (GE) Beats Q3 2025 Estimates, Lifts 2025 Outlook
GE Aerospace reported Q3 revenue of $12.2 billion and EPS of $2.04, beating estimates and raising its full-year guidance on strong demand.
BTC$62,550.00+1.79%
ETH$1,756.59+3.70%
USDT$0.9991+0.02%
USDC$0.9999+0.02%
XRP$1.13+4.56%
SOL$82.28+2.20%
TRX$0.3226+1.69%
FIGR_HELOC$1.01-2.89%
HYPE$70.84+7.66%
DOGE$0.0775+5.22%
RAIN$0.0155-0.39%
USDS$0.9998+0.01%
LEO$9.16+0.34%
ZEC$463.09+7.37%
XLM$0.2045+3.83%
BTC$62,550.00+1.79%
ETH$1,756.59+3.70%
USDT$0.9991+0.02%
USDC$0.9999+0.02%
XRP$1.13+4.56%
SOL$82.28+2.20%
TRX$0.3226+1.69%
FIGR_HELOC$1.01-2.89%
HYPE$70.84+7.66%
DOGE$0.0775+5.22%
RAIN$0.0155-0.39%
USDS$0.9998+0.01%
LEO$9.16+0.34%
ZEC$463.09+7.37%
XLM$0.2045+3.83%
Rocket Lab stock rose 2.7% in premarket trading after announcing its sixth iQPS satellite launch, reinforcing its growing role in the small satellite market.
GE Aerospace reported Q3 revenue of $12.2 billion and EPS of $2.04, beating estimates and raising its full-year guidance on strong demand.
Elevance Health reported Q3 revenue of $50.1 billion and adjusted EPS of $6.03, exceeding expectations and reaffirming its full-year outlook.
Danaher reported Q3 revenue of $6.1 billion and EPS of $1.89, topping estimates and maintaining a positive full-year outlook.
Despite tariff shocks and market jitters, 2025 is shaping up as the strongest year for IPOs since the liquidity boom of 2021.
Archer stock rose over 4% after announcing a partnership with Korean Air to launch electric air taxis in South Korea.
Cleveland-Cliffs stock jumped over 17% after announcing plans to expand into rare earth production at U.S. mining sites.
Robinhood stock has surged 250% in 2025, fueled by its S&P 500 debut and rapid growth across new fintech ventures.
Cooper stock jumped over 6% premarket after Jana Partners took a stake and called for a strategic review.
Oracle shares fell over 7% despite a new Meta partnership, as investors focused on rising costs and execution risks.
As First Brands’ bankruptcy unravels, signs point to a deeper collateral risk brewing across mid-sized lenders.
Artiva Biotherapeutics skyrocketed today after receiving FDA Fast Track status for its AlloNK therapy in refractory rheumatoid arthritis.
Eli Lilly shares fell over 3% in premarket trading after Trump signaled price cuts for weight loss drugs, sparking concerns over future margins.